register

News & Trends - Pharmaceuticals

TGA cautions against over-buying medicines

Health Industry Hub | March 17, 2020 |

Pharma News: In response to COVID-19, the TGA is aware that some pharmacists have been over-ordering medicines, while many consumers have been over-buying. This has resulted in some temporary local level out-of-stock situations, which we expect will resolve in the coming week or two.

It is important to understand that a local out-of-stock is not a national medicine shortage.

The large spike in orders from some pharmacies has resulted in other pharmacies not getting the stock they need. This means that consumers may be unable to get the medicines they need.

Stockpiling medicines may disrupt access to vital medicines by patients and pharmacies.

We call on consumers not to purchase more medicines than they need, and we urge health professionals to reassure patients that there is no need to buy more than is necessary. Health professionals should also avoid prescribing or dispensing multiple months of supply of prescription medicines to patients where there is no clinical need to do so.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.

We call on pharmacists to avoid over ordering medicines, to help ensure that medicines are available to all Australians who need them.

The Department of Health is closely monitoring medicines supply, and working with sponsors, wholesalers and health professional groups to identify and address issues relating to supply.

Australian law requires medicines companies to report current and anticipated shortages of prescription medicines and certain over-the-counter medicines.

We publish shortage notifications for the information of health professionals and consumers, which you can find on the Medicine Shortages Information Initiative web page.

Sponsors are required to report all shortages of reportable medicines. To date, the TGA has not been notified of any medicine shortage as a direct result of the coronavirus.

Customer engagement in COVID-19 times – Keep your people safe and maximise HCP reach digitally. Learn more about how we can assist your team – developed by industry for industry.


Digital & Innovation

Cybersecurity tops investment priorities for ANZ companies

Cybersecurity tops investment priorities for ANZ companies

Health Industry Hub | September 17, 2024 |

Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% […]

More


News & Trends - Pharmaceuticals

Novo Nordisk and Lilly's GLP-1 agonists show promise in type 1 diabetes

Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes

Health Industry Hub | September 17, 2024 |

Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]

More


News & Trends - MedTech & Diagnostics

Health Department’s proposed reporting rules face industry pushback over costs and confidentiality

Health Department’s proposed reporting rules face industry pushback over costs and confidentiality

Health Industry Hub | September 17, 2024 |

MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]

More


News & Trends - MedTech & Diagnostics

Threat to innovation: Health Department’s PL reforms spark industry backlash

Threat to innovation: Health Department’s PL reforms spark industry backlash

Health Industry Hub | September 17, 2024 |

MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]

More


This content is copyright protected. Please subscribe to gain access.